查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600530

生物製藥輔料市場：按產品、特性、應用和最終用戶 - 2025-2030 年全球預測

Biopharmaceutical Excipients Market by Product (Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers), Function (Binders, Coatings, Disintegrants), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 181 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年生物製藥輔料市場價值為22.9億美元，預計2024年將達到25.3億美元，複合年成長率為10.75%，到2030年將達到47億美元。

生物製藥輔料是與藥品活性成分結合，作為載體，提高藥品穩定性、吸收性和可製造性的惰性物質。它在錠劑、膠囊和注射劑等藥物製劑中發揮著至關重要的作用。市場範圍涵蓋口服、局部和腸胃外製劑等各種最終用途。由於人口老化和慢性病的盛行率增加，對生物製藥的需求不斷增加，強調需要先進的賦形劑解決方案來提高藥物療效和患者依從性。一個關鍵的市場成長要素是藥物輸送系統不斷成長的技術創新，為公司提供了開發多功能輔料以滿足特定醫療需求的機會。由於蛋白質和胜肽藥物客製化賦形劑的重要性，生技藥品和生物相似藥市場的擴張進一步推動了需求。根據監管標準和環境考慮，存在開發永續且無害的多功能輔料的機會。然而，市場面臨嚴格的監管要求和開發新輔料的高成本等挑戰。此外，潛在的賦形劑-藥物交互作用和品管問題可能是一個限制。為了實現成長，公司應專注於探索生物相容性和高效的運載工具，包括探索符合綠色化學原則的基於天然聚合物的選擇。這可能會帶來解決安全和環境問題並提高市場競爭力的突破。市場格局是動態的，公司之間的整合不斷增加，以釋放協同效應並增強研發能力。透過新穎的化學結構和先進的製造技術（例如奈米技術）進行創新對於滿足複雜的配方需求至關重要。透過利用這些機會並應對相關挑戰，公司可以促進生物製藥輔料市場的成長，同時培養永續和強大的創新解決方案管道。

主要市場統計
基準年[2023] 22.9億美元
預測年份 [2024] 25.3億美元
預測年份 [2030] 47億美元
複合年成長率（%） 10.75%

市場動態：快速發展的生物製藥輔料市場的關鍵市場洞察

供需的動態交互作用正在改變生物製藥輔料市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 對先進功能性生物製藥配方的需求不斷成長
    • 大分子開發的需求不斷增加
    • 增加生物相似藥的開發
    • 對荷爾蒙療法和基因治療的需求增加
    • 全球疫苗量產
  • 市場限制因素
    • 生物製藥輔料價格高
  • 市場機會
    • 生技藥品製造外包的新趨勢
    • 功能性添加劑的需求顯著增加
    • 重組DNA技術的發展
  • 市場挑戰
    • 製造複雜性和生物製藥輔料污染問題
    • 生物製藥耗時的臨床試驗

波特五力：駕馭生物製藥輔料市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解生物製藥輔料市場的外部影響

外部宏觀環境因素在塑造生物製藥輔料市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解生物製藥輔料市場競爭狀況

對生物製藥輔料市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣生物製藥輔料市場供應商績效評估

FPNV定位矩陣是評估生物製藥輔料市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對先進功能性生物製藥配方的需求不斷成長
      • 對聚合物開發的需求不斷增加
      • 增加生物相似藥的開發
      • 對荷爾蒙和基因治療的需求增加
      • 全球疫苗大規模生產
    • 抑制因素
      • 生物製藥輔料價格高
    • 機會
      • 生物製藥製造外包新趨勢
      • 功能性添加劑需求大幅增加
      • 重組DNA技術的發展
    • 任務
      • 生物製藥輔料製造的複雜性與污染問題
      • 生物製藥耗時的臨床試驗
  • 市場區隔分析
    • 產品：碳水化合物是藥物製劑中用來確保製劑穩定性和患者依從性的主要賦形劑。
    • 功能：提高防腐劑利用率並提高生物製藥的穩定性
    • 應用：生物製藥輔料在先進的藥物控制釋放輸送系統中的重要性日益增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境
  • 客戶客製化

第6章生物製藥輔料市場：依產品

  • 碳水化合物
    • 葡萄糖
    • 澱粉
    • 蔗糖
  • 多元醇
    • 甘露醇
    • 山梨醇
  • 增溶劑和界面活性劑/乳化劑
    • 酯
    • 三酸甘油酯
  • 特殊添加物

第7章生物製藥輔料市場：依功能

  • 活頁夾
  • 塗層
  • 崩壞
  • 潤滑劑和潤滑劑
  • 藥用填充劑
  • 防腐劑

第8章生物製藥輔料市場：依應用分類

  • 先進的輸送系統
  • 口服
  • 胃腸外的
  • 話題

第9章生物製藥輔料市場：依最終用戶分類

  • 契約製造組織
  • 製藥和生物技術公司

第10章美洲生物製藥輔料市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太生物藥輔料市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲/中東/非洲生物藥輔料市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭場景分析
    • 羅蓋特透過推出 PEARLITOL 200 INH 展示了生物製藥輔料的創新。
    • 巴倫支海和亞什蘭之間的戰略協議加強了高純度二聚體二糖輔料在美國生物製藥市場的分銷
    • Rocket推出三類食品補充保濕成分
    • Croda Pharma 開始興建積層製造廠

公司名單

  • ABITEC Corporation
  • Actylis
  • Ashland Global Holdings Inc.
  • BASF SE
  • Clariant International Ltd.
  • Colorcon, Inc.
  • Croda International PLC
  • DFE Pharma GmbH & Co KG
  • Eastman Chemical Company
  • Evonik Industries AG
  • Fuji Chemical Industries Co., Ltd.
  • IMCD NV
  • Innophos Holdings, Inc.
  • J. Rettenmaier & Sohne GmbH+Co KG
  • Meggle Group GmbH
  • Merck KGaA
  • Roquette Freres SA
  • Sigachi Industries Limited
  • Spectrum Laboratory Products, Inc.
  • SPI Pharma, Inc.
  • The Dow Chemical Company
  • The Lubrizol Corporation
  • VWR International, LLC by Avantor
  • Wacker Chemie AG
Product Code: MRR-A339DAEFAD78

The Biopharmaceutical Excipients Market was valued at USD 2.29 billion in 2023, expected to reach USD 2.53 billion in 2024, and is projected to grow at a CAGR of 10.75%, to USD 4.70 billion by 2030.

Biopharmaceutical excipients are inactive substances formulated alongside the active ingredient in a medication, serving as carriers and enhancing the stability, absorption, and manufacturability of pharmaceuticals. They play a pivotal role in drug formulation, including tablets, capsules, and injectable products. The market scope encompasses various end-use applications, such as oral, topical, and parenteral delivery systems. Increasing demand for biopharmaceuticals, driven by an aging population and a rise in chronic disease prevalence, underscores the necessity for advanced excipient solutions that improve drug efficacy and patient compliance. A key market growth factor is the ongoing innovation in drug delivery systems, providing opportunities for companies to develop multifunctional excipients that cater to specific medical needs. The expansion of the biologics and biosimilars markets further propels demand, as excipients tailored for protein and peptide drugs are crucial. Opportunities exist in developing sustainable, non-toxic, and multifunctional excipients that align with regulatory standards and environmental considerations. However, the market faces challenges, such as stringent regulatory requirements and the high cost of developing novel excipients. Additionally, potential excipient-drug interactions and quality control issues may pose limitations. To thrive, companies should focus on research in biocompatible and efficient delivery excipients, including exploring natural polymer-based options which align with green chemistry principles. This could provide a breakthrough in addressing safety and environmental concerns, offering a competitive edge in the market. The market landscape is dynamic, with increasing consolidation among players to harness synergies and enhance R&D capabilities. Innovation is crucial, either through novel chemical structures or advanced manufacturing technologies, such as nanotechnology, to fulfill complex formulation needs. By capitalizing on these opportunities and addressing associated challenges, businesses can drive growth in the biopharmaceutical excipients market while fostering a sustainable and robust pipeline of innovative solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.29 billion
Estimated Year [2024] USD 2.53 billion
Forecast Year [2030] USD 4.70 billion
CAGR (%) 10.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Biopharmaceutical Excipients Market

The Biopharmaceutical Excipients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising Demand for Advanced and Functional Biopharmaceutical Drug Formulations
    • Increasing Need for Large-Molecule Development
    • Increasing Development of Biosimilars
    • Increasing Demand for Hormone and Gene Therapy
    • Bulk Vaccine Production Worldwide
  • Market Restraints
    • High Price of Biopharmaceutical Excipients
  • Market Opportunities
    • Emerging Trends of Outsourcing for the Production of Biologics
    • Substantial Rise in Need of Functional Excipients
    • Developments in Recombinant DNA Technologies
  • Market Challenges
    • Manufacturing Complexities and Contamination Issues of Biopharmaceutical Excipients
    • Time Consuming Biopharmaceutical Clinical Trials

Porter's Five Forces: A Strategic Tool for Navigating the Biopharmaceutical Excipients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Biopharmaceutical Excipients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Biopharmaceutical Excipients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Biopharmaceutical Excipients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Biopharmaceutical Excipients Market

A detailed market share analysis in the Biopharmaceutical Excipients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Biopharmaceutical Excipients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Biopharmaceutical Excipients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Biopharmaceutical Excipients Market, highlighting leading vendors and their innovative profiles. These include ABITEC Corporation, Actylis, Ashland Global Holdings Inc., BASF SE, Clariant International Ltd., Colorcon, Inc., Croda International PLC, DFE Pharma GmbH & Co KG, Eastman Chemical Company, Evonik Industries AG, Fuji Chemical Industries Co., Ltd., IMCD N.V., Innophos Holdings, Inc., J. Rettenmaier & Sohne GmbH + Co KG, Meggle Group GmbH, Merck KGaA, Roquette Freres S.A., Sigachi Industries Limited, Spectrum Laboratory Products, Inc., SPI Pharma, Inc., The Dow Chemical Company, The Lubrizol Corporation, VWR International, LLC by Avantor, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Biopharmaceutical Excipients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Carbohydrates, Polyols, Solubilizers & Surfactants/Emulsifiers, and Specialty Excipients. The Carbohydrates is further studied across Dextrose, Starch, and Sucrose. The Polyols is further studied across Mannitol and Sorbitol. The Solubilizers & Surfactants/Emulsifiers is further studied across Esters and Triglycerides.
  • Based on Function, market is studied across Binders, Coatings, Disintegrants, Lubricants & glidants, Pharmaceutical Fillers, and Preservatives.
  • Based on Application, market is studied across Advanced Delivery System, Oral, Parenteral, and Topical.
  • Based on End User, market is studied across Contract Manufacturing Organizations and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising Demand for Advanced and Functional Biopharmaceutical Drug Formulations
      • 5.1.1.2. Increasing Need for Large-Molecule Development
      • 5.1.1.3. Increasing Development of Biosimilars
      • 5.1.1.4. Increasing Demand for Hormone and Gene Therapy
      • 5.1.1.5. Bulk Vaccine Production Worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High Price of Biopharmaceutical Excipients
    • 5.1.3. Opportunities
      • 5.1.3.1. Emerging Trends of Outsourcing for the Production of Biologics
      • 5.1.3.2. Substantial Rise in Need of Functional Excipients
      • 5.1.3.3. Developments in Recombinant DNA Technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Manufacturing Complexities and Contamination Issues of Biopharmaceutical Excipients
      • 5.1.4.2. Time Consuming Biopharmaceutical Clinical Trials
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Carbohydrates are prominent excipients used in pharmaceutical formulations for formulation stability and patient compliance
    • 5.2.2. Function: Increasing utilization of preservatives in biologic formulation for improved stability
    • 5.2.3. Application: Growing significance of biopharmaceutical excipients in advanced delivery systems for control drug release
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental
  • 5.5. Client Customization

6. Biopharmaceutical Excipients Market, by Product

  • 6.1. Introduction
  • 6.2. Carbohydrates
    • 6.2.1. Dextrose
    • 6.2.2. Starch
    • 6.2.3. Sucrose
  • 6.3. Polyols
    • 6.3.1. Mannitol
    • 6.3.2. Sorbitol
  • 6.4. Solubilizers & Surfactants/Emulsifiers
    • 6.4.1. Esters
    • 6.4.2. Triglycerides
  • 6.5. Specialty Excipients

7. Biopharmaceutical Excipients Market, by Function

  • 7.1. Introduction
  • 7.2. Binders
  • 7.3. Coatings
  • 7.4. Disintegrants
  • 7.5. Lubricants & glidants
  • 7.6. Pharmaceutical Fillers
  • 7.7. Preservatives

8. Biopharmaceutical Excipients Market, by Application

  • 8.1. Introduction
  • 8.2. Advanced Delivery System
  • 8.3. Oral
  • 8.4. Parenteral
  • 8.5. Topical

9. Biopharmaceutical Excipients Market, by End User

  • 9.1. Introduction
  • 9.2. Contract Manufacturing Organizations
  • 9.3. Pharmaceutical & Biotechnology Companies

10. Americas Biopharmaceutical Excipients Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biopharmaceutical Excipients Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biopharmaceutical Excipients Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Roquette showcases innovation in biopharmaceutical excipients with launch of PEARLITOL 200 INH
    • 13.3.2. Strategic agreement between Barentz and Ashland enhances distribution of high-purity Vialose excipient in the United States biopharmaceutical market
    • 13.3.3. Roquette launches three moisture-protecting ingredients for nutraceuticals
    • 13.3.4. Croda Pharma Breaks Ground on Excipients Manufacturing Facility

Companies Mentioned

  • 1. ABITEC Corporation
  • 2. Actylis
  • 3. Ashland Global Holdings Inc.
  • 4. BASF SE
  • 5. Clariant International Ltd.
  • 6. Colorcon, Inc.
  • 7. Croda International PLC
  • 8. DFE Pharma GmbH & Co KG
  • 9. Eastman Chemical Company
  • 10. Evonik Industries AG
  • 11. Fuji Chemical Industries Co., Ltd.
  • 12. IMCD N.V.
  • 13. Innophos Holdings, Inc.
  • 14. J. Rettenmaier & Sohne GmbH + Co KG
  • 15. Meggle Group GmbH
  • 16. Merck KGaA
  • 17. Roquette Freres S.A.
  • 18. Sigachi Industries Limited
  • 19. Spectrum Laboratory Products, Inc.
  • 20. SPI Pharma, Inc.
  • 21. The Dow Chemical Company
  • 22. The Lubrizol Corporation
  • 23. VWR International, LLC by Avantor
  • 24. Wacker Chemie AG

LIST OF FIGURES

  • FIGURE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. BIOPHARMACEUTICAL EXCIPIENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. BIOPHARMACEUTICAL EXCIPIENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. BIOPHARMACEUTICAL EXCIPIENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. BIOPHARMACEUTICAL EXCIPIENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DEXTROSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SUCROSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY MANNITOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SORBITOL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ESTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TRIGLYCERIDES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SPECIALTY EXCIPIENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY BINDERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COATINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY DISINTEGRANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY LUBRICANTS & GLIDANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL FILLERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRESERVATIVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ADVANCED DELIVERY SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. AMERICAS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 50. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ARGENTINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 57. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. BRAZIL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 64. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. CANADA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 71. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. MEXICO BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. UNITED STATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 94. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. AUSTRALIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 101. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. CHINA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 108. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. INDIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 115. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. INDONESIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 122. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. JAPAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 129. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. MALAYSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 136. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. PHILIPPINES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 143. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. SINGAPORE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 150. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. SOUTH KOREA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 157. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. TAIWAN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 164. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. THAILAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 171. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. VIETNAM BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 186. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. DENMARK BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 193. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. EGYPT BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 200. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 201. FINLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 207. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. FRANCE BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 214. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. GERMANY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 221. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. ISRAEL BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 228. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. ITALY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 235. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. NETHERLANDS BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 242. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. NIGERIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 249. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 250. NORWAY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 256. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. POLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 263. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 264. QATAR BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 270. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 271. RUSSIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 277. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. SAUDI ARABIA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 284. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 285. SOUTH AFRICA BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 291. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 292. SPAIN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 298. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 299. SWEDEN BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 305. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 306. SWITZERLAND BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY CARBOHYDRATES, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY POLYOLS, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY SOLUBILIZERS & SURFACTANTS/EMULSIFIERS, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
  • TABLE 312. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 313. TURKEY BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES BIOPHARMACEUTICAL EXCIPIENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES BIOPHARMACEUTICAL EXCIPIENTS MARK